WASHINGTON--(BUSINESS WIRE)--The COPD Foundation today announced the launch of the COPD and Pneumonia Study (CAP), a research initiative designed to describe the burden of pneumonia on individuals living with chronic obstructive pulmonary disease (COPD). COPD, a progressive lung disease characterized by wheezing and breathlessness, affects 30 million Americans. An acute lung infection, such as pneumonia, is potentially fatal for those living with COPD. The CAP study is designed to provide the scientific community with evidence of pneumonia’s impact from the perspective of affected patients.
The CAP study is a multi-stakeholder project comprised of a series of online surveys. The project will expand upon past studies measuring the impact of pneumonia on the general population, but have not specifically observed high risk populations such as those living with COPD. It will address these limitations by utilizing a patient-reported outcomes instrument called CAP-Burden of Illness Questionnaire (CAP-BIQ) as the baseline and for the longitudinal components.
“COPD is a leading cause of death and disability in the U.S., causing 1.5 million emergency room visits annually. Another 3.5 million hospital stays include COPD as a secondary or complicating condition, illustrating the significant comorbid conditions associated with the disease,” said Craig Kephart, chief executive officer of the COPD Foundation. “The incidence rate of pneumonia is 6 to 8 times higher in chronic lung patients - we believe the CAP study will provide us guidance on how to prevent the rise of pneumonia in our community.”
The COPD Foundation will leverage its technology infrastructure provided by the COPD Patient-Powered Research Network (COPD PPRN) to support the study. COPD patients enrolled in the COPD PPRN, who have been diagnosed with pneumonia within a four-month timeframe, will be eligible to participate.
About the COPD Foundation
The COPD Foundation was established to undertake initiatives that result in expanded services for COPD and to improve the lives of individuals affected by COPD. The Foundation’s activities focus on achieving these results through research, education and advocacy programs that will lead to prevention and a cure for this disease. For more information about the COPD Foundation please visit www.copdfoundation.org.